[Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis]. [electronic resource]
Producer: 20120202Description: 113-23 p. digitalISSN:- 1885-1398
- Adalimumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Biological Therapy -- methods
- Drug Therapy, Combination
- Etanercept
- Humans
- Immunoglobulin G -- administration & dosage
- Infliximab
- Methotrexate -- administration & dosage
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Spondylarthritis -- classification
- Sulfasalazine -- administration & dosage
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.